EUVIMEDEUVIMED entdecken
Open Access

Non‐Invasive Transdermal Delivery of miR‐30a‐5p via MUC1‐Aptamer‐Guided Tetrahedral DNA Nanostructures for Gene Silencing in Cutaneous Melanoma

Zhou Jiang, Ziqi Yue, Jiale Liang, Yichen Yang, Yuxuan Zhao, Ye Chen iD, Long Bai, Ruiqing Wang, Songhang Li iD, Yunfeng Lin iD

Small · 2026

DOI: 10.1002/smll.74557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2026. Verfasst von Zhou Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of S…. Hauptthemen laut MEDLINE: MicroRNAs, Melanoma, Gene Silencing, Skin Neoplasms. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Research and Develop Program, West China Hospital of Stomatology Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous malignant melanoma is a highly aggressive skin cancer with poor prognosis. Although microRNA (miRNA)‐based gene therapy shows promise, its clinical translation is limited by rapid degradation in serum and the barrier function of the stratum corneum. Herein, we engineer a programmable, targeted, and non‐invasive nanoplatform, termed MARS (MUC1‐Aptamer‐functionalized, tetrahedral framework nucleic acid‐based miRNA delivery system for gene Silencing). The therapeutic miR‐30a‐5p is encapsulated within a self‐assembled DNA tetrahedron, an architecture that confers exceptional structural stability. The framework is specifically functionalized with an MUC1 aptamer to act as a navigator for active tumor targeting while simultaneously carrying the gene‐silencing payload. In vitro assays demonstrate that MARS successfully delivers miR‐30a‐5p into A375 cells, effectively silencing the transcription factor E2F7 and subsequently triggering the intrinsic apoptotic pathway. Importantly, in vivo studies using a xenograft mouse model reveal that topically applied MARS can penetrate the skin barrier and accumulate in tumor tissues, achieving a tumor growth inhibition rate of 66.86%, comparable to intravenous anti‐PD‐L1 immunotherapy but with superior safety, compliance, and cost‐effectiveness. This study presents MARS as a robust strategy that integrates stability, programmable dual‐functionality (targeting and gene silencing), and non‐invasive transdermal capabilities, providing a promising strategy for localized melanoma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMelanomaGene SilencingSkin NeoplasmsDNA NanostructuresMucin-1Aptamers, NucleotideHumansAnimalsCell Line, TumorAdministration, CutaneousCutaneous Malignant MelanomaMice

Stichwörter der Autor:innen

MUC1cutaneous melanomagene silencemiR‐30a‐5pnon‐invasivetetrahedral framework nucleic acidstransdermal drug delivery

Substanzen

MicroRNAsMucin-1Aptamers, Nucleotide

Autor:innen und Institutionen

  • State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
  • Sichuan Provincial Engineering Research Center of Oral Biomaterials, Chengdu, Sichuan, China.
  • National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai, China.

ORCID-Profile: Ye Chen, Songhang Li, Yunfeng Lin

Förderung

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • Research and Develop Program, West China Hospital of Stomatology Sichuan University
  • Fundamental and Interdisciplinary Disciplines Breakthrough Plan of the Ministry of Education of China
  • Major Science and Technology Special Project of Sichuan Province
  • Leading Scientist Program for Basic Research of Sichuan Province
  • Health Commission of Sichuan Province Medical Science and Technology Program
  • Young Innovation Project of Sichuan Medical Association

Zitieren

APA

Jiang, Z., Yue, Z., Liang, J., Yang, Y., Zhao, Y., Chen, Y., Bai, L., Wang, R., Li, S., & Lin, Y. (2026). Non‐Invasive Transdermal Delivery of miR‐30a‐5p via MUC1‐Aptamer‐Guided Tetrahedral DNA Nanostructures for Gene Silencing in Cutaneous Melanoma. Small. https://doi.org/10.1002/smll.74557

Vancouver

Jiang Z, Yue Z, Liang J, Yang Y, Zhao Y, Chen Y, et al. Non‐Invasive Transdermal Delivery of miR‐30a‐5p via MUC1‐Aptamer‐Guided Tetrahedral DNA Nanostructures for Gene Silencing in Cutaneous Melanoma. Small. 2026. doi:10.1002/smll.74557

BibTeX
@article{Jiang2026,
  author = {Jiang, Zhou and Yue, Ziqi and Liang, Jiale and Yang, Yichen and Zhao, Yuxuan and Chen, Ye and Bai, Long and Wang, Ruiqing and Li, Songhang and Lin, Yunfeng},
  title = {Non‐Invasive Transdermal Delivery of miR‐30a‐5p via MUC1‐Aptamer‐Guided Tetrahedral DNA Nanostructures for Gene Silencing in Cutaneous Melanoma},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.74557}
}
Kostenlos starten →